Sign in
4

Changes in Ownership

ADMA BIOLOGICS, INC. Filed Acc 0001140361-25-020376

Director sold 9,000 shares at an average $20.29 ($182,636)

  • Director acquired 9,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guiheen Lawrence P. Director 2025-05-21 Option exercise +7,779 $5.96 $46,363 122,609 D: show line 1 in the form
Guiheen Lawrence P. Director 2025-05-21 Sale −7,779 $20.32 $158,069 114,830 D: show line 2 in the form
Guiheen Lawrence P. Director 2025-05-22 Option exercise +1,221 $5.96 $7,277 116,051 D: show line 3 in the form
Guiheen Lawrence P. Director 2025-05-22 Sale −1,221 $20.12 $24,567 114,830 D: show line 4 in the form
Open-market sales · 9,000 sh · avg $20.29 · $182,636

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guiheen Lawrence P. Director 2025-05-21 Option exercise · Stock Option (right to buy) −7,779 1,221 D: show line 5 in the form
Guiheen Lawrence P. Director 2025-05-22 Option exercise · Stock Option (right to buy) −1,221 0 D: show line 6 in the form
Loading xslF345X05/form4.xml…